{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:30:46Z","timestamp":1783661446138,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175083"],"award-info":[{"award-number":["175083"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00415-021-10759-4","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T11:02:26Z","timestamp":1630753346000},"page":"2039-2045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Long-term outcome in patients with myasthenia gravis: one decade longitudinal study"],"prefix":"10.1007","volume":"269","author":[{"given":"Ivo","family":"Bozovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Ilic Zivojinovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stojan","family":"Peric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Kostic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vukan","family":"Ivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Lavrnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8768-2136","authenticated-orcid":false,"given":"Ivana","family":"Basta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,4]]},"reference":[{"key":"10759_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.553626","volume":"11","author":"P Szczudlik","year":"2020","unstructured":"Szczudlik P, Sobieszczuk E, Szyluk B et al (2020) Determinants of Quality of Life in Myasthenia Gravis Patients. Front Neurol 11:553626. https:\/\/doi.org\/10.3389\/fneur.2020.553626","journal-title":"Front Neurol"},{"key":"10759_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-015-0298-1","volume":"13","author":"MI Boldingh","year":"2015","unstructured":"Boldingh MI, Dekker L, Maniaol AH, Brunborg C et al (2015) An up-date on health-related quality of life in myasthenia gravis - results from population based cohorts. Health Qual Life Outcomes 13:115. https:\/\/doi.org\/10.1186\/s12955-015-0298-1","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"10759_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.6061\/clinics\/2016(07)03","volume":"71","author":"AM Mour\u00e3o","year":"2016","unstructured":"Mour\u00e3o AM, Gomez RS, Barbosa LSM et al (2016) Determinants of quality of life in Brazilian patients with myasthenia gravis. Clinics (Sao Paulo) 71(7):370\u2013374. https:\/\/doi.org\/10.6061\/clinics\/2016(07)03","journal-title":"Clinics (Sao Paulo)"},{"issue":"497\u2013537","key":"10759_CR4","first-page":"20","volume":"38","author":"KE Osserman","year":"1971","unstructured":"Osserman KE, Genkins G (1971) Studies in myasthenia gravis: review of twenty-year experience in over 1200 patients. Mt Sinai J Med 38(497\u2013537):20","journal-title":"Mt Sinai J Med"},{"key":"10759_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/jnnp.43.7.622","volume":"43","author":"E Stalberg","year":"1980","unstructured":"Stalberg E (1980) Clinical electrophysiology in myasthenia gravis. J Neurol Neurosurg Psychiatry 43:622\u2013633. https:\/\/doi.org\/10.1136\/jnnp.43.7.622","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10759_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s0003-4975(00)01595-2","volume":"55","author":"A Jeretzki","year":"2000","unstructured":"Jeretzki A, Barohn RJ, Ernstoff RM et al (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323. https:\/\/doi.org\/10.1016\/s0003-4975(00)01595-2","journal-title":"Neurology"},{"issue":"6","key":"10759_CR7","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1170-2","volume":"33","author":"I Basta","year":"2012","unstructured":"Basta I, Pekmezovic T, Peric S et al (2012) Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci 33(6):1375\u20131381. https:\/\/doi.org\/10.1007\/s10072-012-1170-2","journal-title":"Neurol Sci"},{"key":"10759_CR8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1037\/\/0022-006x.52.3.343","volume":"2","author":"BJ Felton","year":"1984","unstructured":"Felton BJ, Revenson TA (1984) Coping with chronic illness: a study of illness controllability and influence of coping strategies on psychological adjustment. J Consult Clin Psychol 2:343\u2013353. https:\/\/doi.org\/10.1037\/\/0022-006x.52.3.343","journal-title":"J Consult Clin Psychol"},{"key":"10759_CR9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1080\/00223891.1990.9674095","volume":"55","author":"GD Zimet","year":"1990","unstructured":"Zimet GD, Powell SS, Farley GK et al (1990) Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. J Pers Assess 55:610\u2013617. https:\/\/doi.org\/10.1080\/00223891.1990.9674095","journal-title":"J Pers Assess"},{"issue":"12","key":"10759_CR10","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00415-017-8658-x","volume":"264","author":"I Bozovic","year":"2017","unstructured":"Bozovic I, Kacar A, Peric S et al (2017) Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 264(12):2481\u20132486. https:\/\/doi.org\/10.1007\/s00415-017-8658-x","journal-title":"J Neurol"},{"issue":"2","key":"10759_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1600-0404.2009.01269.x","volume":"122","author":"I Basta","year":"2010","unstructured":"Basta I, Pekmezovic T, Padua L et al (2010) Validation of Serbian version of the disease-specific myasthenia gravis questionnaire. Acta Neurol Scand 122(2):110\u2013114. https:\/\/doi.org\/10.1111\/j.1600-0404.2009.01269.x","journal-title":"Acta Neurol Scand"},{"key":"10759_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/CND.0000000000000122","volume":"18","author":"S Salins","year":"2016","unstructured":"Salins S, Teter B, Kavak K et al (2016) Low-dose medication and long-term outcome in myasthenia gravis. J Clin Neuromusc Dis 18:61\u201366. https:\/\/doi.org\/10.1097\/CND.0000000000000122","journal-title":"J Clin Neuromusc Dis"},{"key":"10759_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/mus.25397","volume":"55","author":"K Utsugisawa","year":"2017","unstructured":"Utsugisawa K, Nagane Y, Akaishi T et al (2017) Early fast-acting treatment strategy against generalised myasthenia gravis. Muscle Nerve 55:794\u2013801. https:\/\/doi.org\/10.1002\/mus.25397","journal-title":"Muscle Nerve"},{"key":"10759_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/mus.25205","volume":"54","author":"JB Andersen","year":"2016","unstructured":"Andersen JB, Gilhus NE, Sanders DB (2016) Factors affecting outcome in myasthenia gravis. Muscle Nerve 54:1041\u20131049. https:\/\/doi.org\/10.1002\/mus.25205","journal-title":"Muscle Nerve"},{"issue":"3","key":"10759_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","volume":"18","author":"G Wolfe","year":"2019","unstructured":"Wolfe G, Kaminski H, Aban I et al (2019) Long-term effect of thymectomy in patients with non-thymomatous myasthenia gravis treated with prednisone: 2-year extension of the MGTX randomised trial. Lancet Neurol 18(3):259\u2013268. https:\/\/doi.org\/10.1016\/S1474-4422(18)30392-2","journal-title":"Lancet Neurol"},{"key":"10759_CR16","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375:2570\u20132581. https:\/\/doi.org\/10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"10759_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T et al (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37:141\u2013149. https:\/\/doi.org\/10.1002\/mus.20950","journal-title":"Muscle Nerve"},{"issue":"8","key":"10759_CR18","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","volume":"256","author":"M Kupersmit","year":"2009","unstructured":"Kupersmit M (2009) Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up. J Neurol 256(8):1314\u20131320. https:\/\/doi.org\/10.1007\/s00415-009-5120-8","journal-title":"J Neurol"},{"issue":"8","key":"10759_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.nmd.2008.05.015","volume":"18","author":"AC Redmond","year":"2008","unstructured":"Redmond AC, Burns J, Ouvrier RA (2008) Factors that influence health-related quality of life in Australian adults with Charcot\u2013Marie\u2013Tooth disease. Neuromuscul Disord 18(8):619\u2013625. https:\/\/doi.org\/10.1016\/j.nmd.2008.05.015","journal-title":"Neuromuscul Disord"},{"key":"10759_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000506879","volume":"89","author":"D Carrozzino","year":"2020","unstructured":"Carrozzino D, Patierno C, Fava G et al (2020) The hamilton rating scales for depression: A critical review of clinimetric properties of different versions. Psychother Psychosom 89:133\u2013150. https:\/\/doi.org\/10.1159\/000506879","journal-title":"Psychother Psychosom"},{"issue":"7","key":"10759_CR21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9184","volume":"12","author":"C Law","year":"2020","unstructured":"Law C, Flaherty CV, Bandyopadhyay S (2020) A review of psychiatric comorbidity in myasthenia gravis. Cureus 12(7):e9184. https:\/\/doi.org\/10.7759\/cureus.9184","journal-title":"Cureus"},{"issue":"11","key":"10759_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206754","volume":"13","author":"A Jeong","year":"2018","unstructured":"Jeong A, Min JH, Kang YK (2018) Factors associated with quality of life of people with Myasthenia Gravis. PLoS ONE 13(11):e0206754. https:\/\/doi.org\/10.1371\/journal.pone.0206754","journal-title":"PLoS ONE"},{"key":"10759_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s100720100066","volume":"22","author":"L Padua","year":"2001","unstructured":"Padua L, Evoli A, Aprile I et al (2001) Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci 22:363\u2013369. https:\/\/doi.org\/10.1007\/s100720100066","journal-title":"Neurol Sci"},{"key":"10759_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","volume":"8","author":"S Twork","year":"2010","unstructured":"Twork S, Wiesmeth S, Klewer J et al (2010) Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 8:129. https:\/\/doi.org\/10.1186\/1477-7525-8-129","journal-title":"Health Qual Life Outcomes"},{"key":"10759_CR25","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-010-5549-9","volume":"257","author":"Y Winter","year":"2010","unstructured":"Winter Y, Schepelmann K, Spottke AE et al (2010) Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 257:1473\u20131481. https:\/\/doi.org\/10.1007\/s00415-010-5549-9","journal-title":"J Neurol"},{"issue":"13","key":"10759_CR26","doi-asserted-by":"publisher","first-page":"e1497","DOI":"10.1212\/WNL.0000000000007190","volume":"92","author":"KE Harding","year":"2019","unstructured":"Harding KE, Wardle M, Carruthers R et al (2019) Socioeconomic status and disability progression in multiple sclerosis: a multinational study. Neurology 92(13):e1497\u2013e1506. https:\/\/doi.org\/10.1212\/WNL.0000000000007190","journal-title":"Neurology"},{"key":"10759_CR27","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1136\/bmj.316.7145.1631","volume":"316","author":"GD Smith","year":"1998","unstructured":"Smith GD, Hart C, Blane D et al (1998) Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study. BMJ 316:1631\u20131635. https:\/\/doi.org\/10.1136\/bmj.316.7145.1631","journal-title":"BMJ"},{"key":"10759_CR28","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/ene.12586","volume":"22","author":"R Goulden","year":"2015","unstructured":"Goulden R, Ibrahim T, Wolfson C (2015) Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review. Eur J Neurol 22:899\u2013911. https:\/\/doi.org\/10.1111\/ene.12586","journal-title":"Eur J Neurol"},{"key":"10759_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/ene.12830","volume":"23","author":"R Goulden","year":"2016","unstructured":"Goulden R, Riise T, Myhr KM et al (2016) Does low socioeconomic status in early life protect against multiple sclerosis? A multinational, case-control study. Eur J Neurol 23:168\u2013174. https:\/\/doi.org\/10.1111\/ene.12830","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10759-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10759-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10759-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T16:09:39Z","timestamp":1647965379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10759-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10759"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10759-4","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,4]]},"assertion":[{"value":"23 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"This research was approved by the Ethical Committee of the Faculty of Medicine, University of Belgrade (decision 2650\/x-11).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Each author has read and approved the final manuscript version for submission.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}